COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,015 Articles (22,627 medRxiv, 8,388 bioRxiv)

Most recent first Previous |  Page 37: Articles 361-370  | Next

Rationally Designed, ACE2 Mimetic Binder to the SARS Cov-2 Associated Spike Protein for COVID-19 Therapeutics and Beyond
Peters, M. H., Pei, X. Y.
10.1101/2025.06.05.658001 — Posted: 2025-06-06
Olfactory cleft obstruction in post-COVID-19 olfactory disorder: CT Comparison with post-viral cases
Tanaka, H., Mori, E., Kishimoto, Y., Yonezawa, N., Sekine, R., Nagai, M., Tei, M., Otori, N.
10.1101/2025.06.04.25328964 — Posted: 2025-06-05
Work absenteeism across economic activity sectors and its association with COVID-19-like illness prevalence in the Netherlands, 2020-2023
Korthals Altes, H., van de Kassteele, J., Wisse, B., Xiridou, M., van Hoek, A. J., Wallinga, J.
10.1101/2025.05.26.25328340 — Posted: 2025-06-04
CellVoyager: AI CompBio Agent Generates New Insights by Autonomously Analyzing Biological Data
Alber, S., Chen, B., Sun, E., Isakova, A., Wilk, A. J., Zou, J.
10.1101/2025.06.03.657517 — Posted: 2025-06-04
SARS-CoV-2 detection is independent of microbiome composition on surfaces in a major Ontario hospital
George, N. A., Bradford, L., Hinz, A., El Kadi, M., Xing, L., Doukhanine, E., MacFadden, D. R., Nott, C., Fralick, M., Kassen, R., Wong, A., Hug, L.
10.1101/2025.06.03.25328878 — Posted: 2025-06-03
Multi-Omic Profiling Identifies Conserved Metabolic Pathways Critical for SARS-CoV-2 Variants Infection
Farley, S. E., Kyle, J. E., Jahn, H., Bramer, L., Piehowski, P., Shepmoes, A., Kaiser, B. L., Williams, S. M., Eder, J. G., Schultz, C., Tafesse, F.
10.1101/2025.06.02.657371 — Posted: 2025-06-03
The Role of SARS-CoV-2 Nucleocapsid Protein Persistence in Inducing Chronic Type I Interferon and Mitochondrial Dysfunction.
Koenig, A., Quasem, M., Zink, B., Abdulla-Zoda, D., Karunanidhi, P., Sienko, K., Geier, C., Jayaraman, V., Malik, R., Ahmed, K., Shanley, P. F., Koenig, I. A.
10.1101/2025.06.02.657400 — Posted: 2025-06-03
Impact of first SARS-CoV-2 infection variant on serological responses against Omicron: findings from the SIREN study
Insalata, F., Atti, A., Carr, E. J., Otter, A. D., SIREN study group, , Foulkes, S., Dowgier, G., Hobbs, A., Wu, M. Y., Hopkins, S., Charlett, A., Beale, R., Hall, V. J.
10.1101/2025.06.02.25328497 — Posted: 2025-06-02
Diverse tendencies in codon usage evolution of SARS-CoV-2 genes
Blazej, P., Mackiewicz, D., Mackiewicz, P.
10.1101/2025.05.30.657095 — Posted: 2025-06-02
Long-term risk of post-acute sequelae among adults following SARS-CoV-2 or influenza virus infection: a retrospective cohort study in a large, integrated healthcare system
Lewnard, J. A., Malden, D. E., Hong, V., Skela, J., Feldstein, L. R., Saydah, S., Reyes, I. A. C., Hechter, R. C., Sy, L. S., Ackerson, B. K., Tartof, S. Y.
10.1101/2025.05.30.25328674 — Posted: 2025-06-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).